Rhumbline Advisers Reduces Position in Tourmaline Bio, Inc. (NASDAQ:TRML)
Rhumbline Advisers trimmed its position in Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 7.2% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 33,033 shares of the company’s stock after selling 2,558 shares during the period. Rhumbline Advisers’ holdings in Tourmaline Bio were worth $502,000 at […]
Rhumbline Advisers trimmed its position in Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 7.2% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 33,033 shares of the company’s stock after selling 2,558 shares during the period. Rhumbline Advisers’ holdings in Tourmaline Bio were worth $502,000 at […]
